The eyes as possible windows into MS
Two recent scientific publications add further evidence that a simple eye test may offer a fast and easy way to monitor the progression of MS.
Last updated: 24th January 2018
As the old proverb goes, the eyes are the window to the soul. Whoever penned those words probably had no idea how relevant that statement would be for MS, as the eyes might prove to be an easy non-invasive way to monitor MS progression.
Measuring the thickness of the layer of nerve cells at the back of the eye (the retina) might become a great tool to track MS. The retinal nerve fibre layer gets thinner in people with MS, and, given the relative ease with which we can look at the back of the eye, this might become a relatively cheap and quick method to regularly monitor MS progression.
Two studies have recently been published looking at retinal thinning and MS. The first study, produced in Italy, examines potential changes in the nerve layer when other measures fail to detect disease activity, otherwise known as No Evidence of Disease activity (NEDA). NEDA is often defined as no clinical relapse, no worsening of disabilities, and no new lesions detected on a MRI. In this Italian study, the researchers looked at 72 patients and carried out a number of tests, including MRI and other clinical measures. They also measured the optical nerve at two separate visits, around two years apart.
In this study, people with a greater thinning of the nerve fibre layer at the back of the retina were more likely to develop new brain lesions, which were detected on MRIs. Additionally, the increased thinning was also indicative of worsening disabilities.
Overall, when they looked at both eyes of people with NEDA, less thinning was detected than in those who had clear signs of disease activity. This suggests that this could be a simple measure to detect disease activity.
Of concern is that some people with MS can suffer bouts of optic neuritis, in which the immune system attacks the nerves associated with the eyes. Previous reports suggest that these attacks can enhance the thinning of these nerves. This could complicate this potential test, leading to a diagnosis of a higher level of disease progression than has actually occurred. However, in this study, the scientists found that previous attacks of optic neuritis did not influence the rate of retinal nerve fibre thinning when averaged out over two years. This was further confirmed by the second report, which analysed the changes in the retinal nerve fibre layer in the eyes over five years. They compared the rate of thinning in people with MS who had and had not experienced optic neuritis.
This study showed that in people who had experienced attacks of optic neuritis, their retinal nerve fibres were thinner than the fibres from people who had not. However, while optic neuritis can cause temporary periods of accelerated thinning, once the attack stops, the overall rate of thinning is unaffected. This suggests that, over time, the rate of change in the eye can be a marker for what is going on deeper in the brain.
Together, these studies suggest that looking at the nerve fibres at the back of the eye could provide a relatively cheap, non-invasive way to measure the level of MS activity occurring generally in the brain and in other parts of the body. This would help guide therapeutic decisions and help to determine whether the correct treatment is being used.
With thanks to MS Research Australia – the lead provider of research summaries on our website.